Short Description Tithonus Therapeutics focuses on partial reprogramming vectors to promote healthy aging.
Description Tithonus Therapeutics is a biotechnology company advancing research and development in the field of partial reprogramming vectors. The organization combines scientific rigor with innovative technology to translate discoveries in genetic therapy into real‑world interventions aimed at extending both lifespan and healthspan. By targeting fundamental mechanisms of aging, Tithonus Therapeutics aims to deliver impactful solutions that help individuals live longer, healthier lives.